Sharad Kumar

Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors

J. Melo, R. D'Andrea, Angel F. Lopez, 2010, Leukemia.

Non-Adherence in Patients of Inflammatory Bowel Disease

S. J. Bhyan, H. Imran, R. Chauhan, 2020 .

Short-term intense Bcr–Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL+ cells

J. Melo, D. White, T. Hughes, 2009, Leukemia.